Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survodutide for the Treatment of Obesity: Rationale and Design of the SYNCHRONIZE Cardiovascular Outcomes Trial.
Kosiborod MN, Platz E, Wharton S, le Roux CW, Brueckmann M, Ajaz Hussain S, Unseld A, Startseva E, Kaplan LM; SYNCHRONIZE–CVOT Trial Committees and Investigators. Kosiborod MN, et al. Among authors: startseva e. JACC Heart Fail. 2024 Oct 23:S2213-1779(24)00662-0. doi: 10.1016/j.jchf.2024.09.004. Online ahead of print. JACC Heart Fail. 2024. PMID: 39453356 Free article. Review.
Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trial.
Tack CJ, Jacob S, Desouza C, Bain SC, Buse JB, Nauck MA, Petrie JR, Poulter NR, Pratley RE, Stegmann HVBK, Bosch-Traberg H, Startseva E, Zinman B; LEADER Publication Committee on behalf of the LEADER Trial Investigators. Tack CJ, et al. Among authors: startseva e. Diabetes Obes Metab. 2019 Nov;21(11):2450-2458. doi: 10.1111/dom.13826. Epub 2019 Jul 7. Diabetes Obes Metab. 2019. PMID: 31282028 Free PMC article. Clinical Trial.
Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo-controlled, dose-finding, phase 2 trial.
le Roux CW, Steen O, Lucas KJ, Ekinci EI, Startseva E, Unseld A, Hussain SA, Hennige AM. le Roux CW, et al. Among authors: startseva e. Diabetes Obes Metab. 2024 Nov 25. doi: 10.1111/dom.16052. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 39582349 No abstract available.
[Meadow maris: a genetic landscape].
El'chinova GI, Startseva EA, Moshkina IS, Ginter EK. El'chinova GI, et al. Among authors: startseva ea. Genetika. 1998 May;34(5):671-5. Genetika. 1998. PMID: 9719915 Russian.
[Meadow Maris: genes, surnames and migrations].
El'chinova GI, Kravchuk OI, Startseva EA, Moshkina IS, Rassanov VP, Spitsyn VA, Ginter EK. El'chinova GI, et al. Among authors: startseva ea. Genetika. 1996 Oct;32(10):1421-2. Genetika. 1996. PMID: 9091416 Russian.
[The meadow Mari: inbreeding and endogamy].
El'chinova GI, Startseva EA, Moshkina IS, Rassanov VP, Ginter EK. El'chinova GI, et al. Among authors: startseva ea. Genetika. 1996 Sep;32(9):1302-4. Genetika. 1996. PMID: 9026471 Russian.
23 results